The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for ...

DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food and Drug Administration for a new glucose monitoring system. Shares of the ...

DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...

This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose Monitoring System, marking a significant advancement in diabetes management ...

The role of Continuous Glucose Monitoring (CGM) system like Dexcom G7 in Nick's diabetes journey Nick’s message also highlighted the Dexcom G7, a continuous glucose monitoring (CGM) system that ...

According to Yogish C. Kudva, Division of Endocrinology, Diabetes, Nutrition, Mayo Clinic, Rochester, Minnesota, USA, and ...

Personal continuous glucose monitors are accurate at measuring glucose levels in most ranges for hospitalized patients with ...

The FDA warned that several hundred units of counterfeit 1-mg semaglutide (Ozempic) were found in the U.S. drug supply chain ...

Glucose values in patients with type 1 diabetes (T1D) may vary based on the continuous glucose monitoring (CGM) system used ... Abbott Diabetes Care), Dexcom G7 (DG7; Dexcom Inc), and Medtronic ...